Descripción
About the Role: - Brands in-scope: Oveporexton - Be an active member of the Takeda’s access community and value chain that ensure patients have access to innovative treatments ensuring timely, sustainable reimbursement and uptake through robust payer value propositions, evidence generation, HTA readiness, and effective cross-functional delivery. - Work very closely with Global Access Strategy team to ensure execution within IBU. - Lead and own IBU access strategy, provide strategic inputs for 6 core markets, and execute market access readiness across international markets for Oveporexton. Ensure integrating disease‑area insights, payer expectations, competitive intelligence, and evidence‑generation requirements to inform IBU decisions and maximize patient access in international markets. - Act as a core member of cross‑functional teams, working with global and IBU partners (Commercial, Medical Affairs, Regulatory, HEOR, Global Access & Pricing, Pipeline, etc.) to embed access considerations into key strategic decisions. - Be part of Global Pricing and Access (GPA) function, contributing to advance GPA governance and ways of working, to influencing functional excellence (Access, Pricing, cross‑TA collaboration, capability building) and to shaping the access vision and capability roadmap. How you will contribute: IBU - Oveporexton Access Business Partner - Plan and execute initiatives across IBU markets to ensure the global access and pricing strategy’s success of Oveporexton in a competitive, highly regulated environment. - Serve as primary point of contact for IBU Local Access teams for Oveporexton; drive access and pricing strategy execution to enable timely patient access, including P&R success through strong HTA readiness and payer negotiation preparedness, as well as sustained value maximization across life cycle management. - Partner with LOCs to set the right ambition for LOCs and guide the LOCs with the scenario planning and access plan development to maximiz